DarioHealth Corp. (DRIO)
NASDAQ: DRIO · Real-Time Price · USD
7.11
+0.02 (0.28%)
At close: Sep 12, 2025, 4:00 PM EDT
7.10
-0.01 (-0.14%)
After-hours: Sep 12, 2025, 7:09 PM EDT

DarioHealth Statistics

Total Valuation

DarioHealth has a market cap or net worth of $17.06 million. The enterprise value is $26.73 million.

Market Cap17.06M
Enterprise Value 26.73M

Important Dates

The next estimated earnings date is Thursday, November 6, 2025, before market open.

Earnings Date Nov 6, 2025
Ex-Dividend Date n/a

Share Statistics

DarioHealth has 2.40 million shares outstanding. The number of shares has increased by 63.26% in one year.

Current Share Class 2.40M
Shares Outstanding 2.40M
Shares Change (YoY) +63.26%
Shares Change (QoQ) +4.77%
Owned by Insiders (%) 11.83%
Owned by Institutions (%) 19.16%
Float 2.10M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 0.71
Forward PS 0.53
PB Ratio 0.25
P/TBV Ratio n/a
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 0.98
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 3.30, with a Debt / Equity ratio of 0.49.

Current Ratio 3.30
Quick Ratio 2.77
Debt / Equity 0.49
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -66.92% and return on invested capital (ROIC) is -26.75%.

Return on Equity (ROE) -66.92%
Return on Assets (ROA) -22.55%
Return on Invested Capital (ROIC) -26.75%
Return on Capital Employed (ROCE) -42.18%
Revenue Per Employee $134,396
Profits Per Employee -$176,811
Employee Count202
Asset Turnover 0.24
Inventory Turnover 1.70

Taxes

In the past 12 months, DarioHealth has paid $164,000 in taxes.

Income Tax 164,000
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -55.00% in the last 52 weeks. The beta is 1.11, so DarioHealth's price volatility has been higher than the market average.

Beta (5Y) 1.11
52-Week Price Change -55.00%
50-Day Moving Average 11.17
200-Day Moving Average 13.39
Relative Strength Index (RSI) 31.32
Average Volume (20 Days) 33,101

Short Selling Information

The latest short interest is 162,810, so 6.78% of the outstanding shares have been sold short.

Short Interest 162,810
Short Previous Month 3.13M
Short % of Shares Out 6.78%
Short % of Float 7.74%
Short Ratio (days to cover) 11.32

Income Statement

In the last 12 months, DarioHealth had revenue of $27.15 million and -$35.72 million in losses. Loss per share was -$13.13.

Revenue27.15M
Gross Profit 18.87M
Operating Income -41.58M
Pretax Income -52.73M
Net Income -35.72M
EBITDA -35.26M
EBIT -41.58M
Loss Per Share -$13.13
Full Income Statement

Balance Sheet

The company has $21.95 million in cash and $31.62 million in debt, giving a net cash position of -$9.67 million or -$4.03 per share.

Cash & Cash Equivalents 21.95M
Total Debt 31.62M
Net Cash -9.67M
Net Cash Per Share -$4.03
Equity (Book Value) 63.99M
Book Value Per Share 28.14
Working Capital 22.42M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$26.79 million and capital expenditures -$128,000, giving a free cash flow of -$26.92 million.

Operating Cash Flow -26.79M
Capital Expenditures -128,000
Free Cash Flow -26.92M
FCF Per Share -$11.22
Full Cash Flow Statement

Margins

Gross margin is 69.49%, with operating and profit margins of -153.15% and -162.73%.

Gross Margin 69.49%
Operating Margin -153.15%
Pretax Margin -162.13%
Profit Margin -162.73%
EBITDA Margin -129.87%
EBIT Margin -153.15%
FCF Margin n/a

Dividends & Yields

DarioHealth does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -63.26%
Shareholder Yield -63.26%
Earnings Yield -209.32%
FCF Yield -157.78%

Analyst Forecast

The average price target for DarioHealth is $50.00, which is 603.24% higher than the current price. The consensus rating is "Strong Buy".

Price Target $50.00
Price Target Difference 603.24%
Analyst Consensus Strong Buy
Analyst Count 2
Revenue Growth Forecast (5Y) 18.34%
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

The last stock split was on August 28, 2025. It was a reverse split with a ratio of 1:20.

Last Split Date Aug 28, 2025
Split Type Reverse
Split Ratio 1:20

Scores

DarioHealth has an Altman Z-Score of -5.84 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -5.84
Piotroski F-Score 4